Chikungunya Outbreaks Caused by African Genotype, India by Yergolkar, Prasanna N. et al.
Chikungunya
Outbreaks Caused
by African
Genotype, India 
Prasanna N. Yergolkar,* Babasaheb V. Tandale,*
Vidya A. Arankalle,* Padmakar S. Sathe,* 
Sudeep A. B.,* Swati S. Gandhe,* 
Mangesh D. Gokhle,* George P. Jacob,* 
Supriya L. Hundekar,* and Akhilesh C. Mishra*
Chikungunya fever is reported in India after 32 years.
Immunoglobulin M antibodies and virus isolation confirmed
the cause. Phylogenic analysis based on partial sequences
of NS4 and E1 genes showed that all earlier isolates
(1963–1973) were Asian genotype, whereas the current
and Yawat (2000) isolates were African genotype. 
C
hikungunya virus (CHIKV) outbreaks have been doc-
umented in Africa and Southeast Asia. In India, the
first CHIKV outbreak was recorded in 1963 in Calcutta
and was followed by epidemics in Chennai, Pondicherry,
and Vellore in 1964; Visakhapatnam, Rajmundry, and
Kakinada in1965; Nagpur in1965; and Barsi in 1973 (1).
Recently, CHIKV has emerged in Southeast Asia and the
Pacific region (2–4). Massive outbreaks have been report-
ed from many islands in the Indian Ocean (5).  Aedes
albopictus is considered the vector in Reunion and other
islands in the Indian Ocean (5), but Ae. aegypti is the main
vector in Asia, including India (1). We investigated a large
number of patients with fever with arthralgia, reported
from October 2005 through March 2006, in many districts
from Andhra Pradesh, Karnataka, and Maharashtra states. 
The Study
Blood samples were collected from 1,938 suspected
case-patients from the 3 states; serum was separated and
transported to the laboratory on wet ice. Adult mosquitoes
were collected from houses and sheds. Larval mosquitoes
were collected from the affected areas by single-larva sur-
vey method. Adult household indexes and Breteau indexes
were calculated for each area (6).
The C6/36 cell line was used for virus isolation (7).
Immunoglobulin M (IgM) antibodies to CHIKV(IgM anti-
CHIK) and dengue virus (IgM anti-dengue) (8) were
assayed by IgM capture ELISA. For CHIKV ELISA, brain
suspensions from mice infected with CHIKV were the
source of antigen, and monoclonal antibodies were the
source of antibodies (9). Dengue/CHIKV IgM antibodies
and negative control human sera were included for respec-
tive tests. Approval for use of mice for antigen preparation
was obtained from the institutional ethical committee
according to national guidelines.
Immunofluorescence assay (IFA) was used to detect the
virus in cell culture and in crushed heads of adult mosqui-
toes (10). A patient with the following was confirmed as
having CHIKV infection: acute onset of moderate-to-high
fever with joint pain of varying severity; negative test
results for malaria, typhoid, and tuberculosis; and positive
results for IgM anti-CHIKV antibodies, seroconversion, or
CHIKV isolation. We used χ2 test to compare proportions
of cases in different age groups.
We studied CHIKV isolates obtained during current
investigations and viruses isolated during earlier epi-
demics in India (1963–2000) (Table 1). RNA was isolated
by using QIAamp Viral RNA Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Superscript II (Invitrogen, Carlsbad, CA, USA) was used
for reverse transcription (42°C for 1 h). Initially,
Alphavirus genus–specific primers that produced a 472-bp
fragment (NS4 gene) were F1 5′ GAY GCI TAYYTI GAY
ATG GTI GAI GG 3′ and R1 5′ KYT CYT CIG TRT GYT
TIG TIC CIGG 3′ (11). The second set of primers that
amplified a 294-bp product of E1 gene were CHIK/E1-S 5′
TAC CCA TTC ATG TGG GGC 3′ and CHIK/E1-C 5′
GCC TTT GTA CAC CAC GATT 3′ (12). For amplifica-
tion, Platinum Pfx enzyme (Invitrogen) was used. Cycling
conditions were 1 cycle at 94°C for 5 min; then 35 cycles
each of 94°C (1 min), 50°C (1 min), and 68°C (1.5 min);
followed by final extension of 7 min at 68°C. The PCR
products were purified by using QIAquick PCR
Purification Kit (Qiagen) and sequenced by using BigDye
Terminator Cycle Sequencing Ready Reaction Kit
(Applied Biosystems, Foster City, CA, USA) and an auto-
matic sequencer (ABI PRISM 3100 Genetic Analyzer,
Applied Biosystems).
Using ClustalX, version 1.83, multiple alignments of
nucleotide sequences were performed. The phylogenic sta-
tus of the CHIKV isolates was assessed with the software
MEGA 3.1 (13), Kimura 2-parameter distance, and neigh-
bor-joining algorithm. The reliability of different phylo-
genic groupings was evaluated with the bootstrap test
(1,000 bootstrap replications) available in MEGA.
Acute onset of moderate-to-high fever in association
with body ache, backache, and headache was recorded.
Joint pain of varying severity occurred within 2 days of
onset of fever and, in decreasing order of affliction,
involved knees, ankles, wrists, hands, and feet. Joint pain
was severe and incapacitating and lasted for weeks to
months. Inflammation of joints and transient macular rash
on earlobes, neck, trunk, and upper extremities were
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*National Institute of Virology, Pune, Indiareported for a few patients. Hemorrhage did not occur. The
cases were reported predominantly from rural areas; distri-
bution was focal. Multiple cases were recorded in families.
All ages and both sexes were affected; significantly more
cases occurred in persons aged >15 years (299 [89.8%] of
333, p<0.001). Cases were reported from 11 of 23 districts
in Andhra Pradesh, 15 of 27 in Karnataka, and 16 of 35 in
Maharashtra (Figure 1). Results of serologic testing and
virus isolation are shown in Table 2.
State governments of Andhra Pradesh, Karnataka, and
Maharashtra have declared outbreaks of CHIKV. By mid-
April, the declared numbers of fever cases associated with
this outbreak were >25,000 in Andhra Pradesh, >65,000 in
Maharashtra, and >36,000 in Karnataka. In absence of
active surveillance for this disease, these numbers may be
underestimates.
The predominant mosquito species in the affected areas
was Ae. aegypti. Ae. albopictus was either absent or pres-
ent in negligible numbers. The population of Ae. aegypti
was reasonably high in most of the localities; adult house-
hold indexes and Breteau indexes, respectively, were
10–60 and 13–75 in Andhra Pradesh, 20–70 and 40–200 in
Karnataka, and 10–30 and 30–50 in Maharashtra. High
density of Ae. aegypti populations in affected areas and 23
isolations or detections of CHIKV from adult mosquitoes
indicates that this species is the main vector in India.
Earlier outbreaks in India were mainly restricted to large
cities; in contrast, the current outbreak is predominantly
rural.
Anti-CHIKV IgM was detected in 33.5% to 41.9% of
patients tested. The finding of antibodies to dengue virus
in 0.9% to 9.9% of patients and to CHIKV and dengue
virus in 0.4% to 4.3% of patients indicates that these virus-
es cocirculate in the area. Nine patients whose acute-phase
serum sample was negative had anti-CHIKV IgM in the
early convalescent-phase sample, collected during the sec-
ond week of illness.
NS4-based phylogenic analysis identified the Yawat
isolate (2000) from Maharashtra as central/East African
genotype, not Asian genotype as reported earlier (14). This
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Figure 1. Southern India, 3 states affected by chikungunya virus
(October 2005–March 2006). Gray shading indicates area affect-
ed in each state.finding led us to resequence all isolates in our repository.
Phylogenic analyses based on NS4 (Figure 2A) and E1
regions (Figure 2B) yielded identical results. The Indian
viruses isolated from 1963 through 1973 belonged to the
Asian genotype, whereas the current isolates from the 3
Indian states and the Yawat isolate belonged to the cen-
tral/East African genotype. Within the Asian genotype, all
older isolates (India 1963–1973 and Thailand 1962–1978)
clustered together, whereas later isolates from the
Philippines (1985), Indonesia (1985), Thailand (1988,
1995, 1996), and Malaysia (1998) formed a distinct clus-
ter. The sequence from Reunion Islands, which represents
a recent outbreak of the disease (GenBank accession no.
DQ443544), also grouped with the recent Indian isolates.
Percentage nucleotide identity within earlier (1963–1973)
and recent (2005–2006) Indian isolates was 99.71% ±
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Figure 2. Phylogenic analyses of partial NS4 (456 nt, panel A) and E1 (294 nt, panel B). Refer to Table 1 for the details of the isolates
sequenced during this study. Percentage bootstrap support is indicated by the values at each node. The following sequences were
obtained from GenBank database: E1, ROSS (AF490259); S27Africa (NC-004162); Tanz53 (AF192905); Africa76 (AF192903); CONGO1
(AY549583); CONGO2 (AY549581); CONGO3 (AY549579); Uganda82 (AF192907); Thai95 (AF192897); Thai96 (AF192900); Thai88
(AF192896); Thai62 (AF192908); Thai75 (AF192898); Thai78 (AF192899); Philip85 (AF192895); Indon85 (AF192894); Malay98A
(AF394210); Malay98B (AF394211); Seneg83A (AY726732); ONY-UG96 (AF079456); Reuni06 (DQ443544); Seneg83B (AF192892);
Niger64 (AF192893); Seneg66 (AF192891); NS1, UK/S27 (AF345888); ROSS (AF490259); S27Africa (NC-004162); Seneg83A
(AY726732); ONY-UG96 (AF079456); and Reuni06 (DQ443544). O'nyong-nyong virus (AF079456) was used as an outgroup.0.16% and 99.94% ± 0.05%, respectively, whereas per-
centage nucleotide identity between these isolates was
96.11% ± 1.09%. The 2005–2006 Indian isolates were
98.61% ± 0.6% and 98.95% ± 0.57% identical with the
Reunion and Yawat isolates, respectively.
Conclusions
This report confirms CHIKV as the causative agent for
large outbreaks of fever with arthralgia and arthritis in 3
Indian states. Thus, chikungunya fever has emerged in out-
break form after 32 years.
The current epidemic is caused by central/East African
genotype of CHIKV. That the Yawat isolate is grouped
with central/East African genotype suggests that this geno-
type had been introduced >5 years before the current out-
breaks. In this context, determining the genotype of
currently circulating strains in Southeast Asia and under-
standing the modes of transportation of this strain in India
and the conditions favoring such large outbreaks would be
worthwhile.
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